3 hours HC Wainwright Reaffirms Buy Rating for Voyager Therapeutics (NASDAQ:VYGR)MarketBeat
HC Wainwright restated a “buy” rating and issued a $30.00 price target on shares of Voyager Therapeutics in a research note on Thursday.
XHC Wainwright restated a “buy” rating and issued a $30.00 price target on shares of Voyager Therapeutics in a research note on Thursday.
X